# re.Mind Capital

> re.Mind Capital is a VC fund in Sliema backing Medical and Health Care. See 19 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Sliema, Malta
- Total investments: 19
- Last investment: Jan 2024
- Lead investor: 26%
- Last updated: Aug 2026
- Website: https://remind.vc/

re.Mind Capital is a VC fund in Sliema focused on Medical and Health Care. re.Mind Capital is the mental health VC arm of serial entrepreneur and investor Christian Angermayer and his family office Apeiron Investment Group.

## Contacts

5 contacts available for re.Mind Capital. Shizune tracks 1 team members at re.Mind Capital. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/re-mind-capital?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 7 | 37% |
| Health Care | 7 | 37% |
| Biotechnology | 6 | 32% |
| Neuroscience | 4 | 21% |
| Medical Device | 4 | 21% |

25 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 8 | 42% |
| Seed | 3 | 16% |
| Series B | 3 | 16% |
| Pre-Seed | 1 | 5% |
| Funding Round | 1 | 5% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 12 | 63% |
| United Kingdom | 3 | 16% |
| Germany | 1 | 5% |
| Switzerland | 1 | 5% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Jan Hardorp | Founding Partner | 3 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Motif Neurotech | Motif Neurotech is a company that develops minimally invasive bioelectronic implants for monitoring and treating severe mental illnesses. | $18.8M | Series A | Jan 24, 2024 |  |
| Precision Neuroscience | Precision Neuroscience is a neural platform for next-generation brain-computer interface technology. The company's goal is to provide breakthrough treatments for the one billion patients worldwide suffering from neurological illnesses. Its brain–computer interface is designed to be minimally invasive, safely removable, and capable ofprocessing large amounts of data.The company was founded in 2021 and is based in New York. | $41M | Series B | Jan 25, 2023 |  |
| Sensorium Therapeutics | Sensorium Therapeutics is a drug discovery platform that develops novel FDA-approved psychoactive medicines. Founded in 2021, the company is based in Boston, Massachusetts. | $30M | Series A | Oct 04, 2022 |  |
| iLoF | iLoF - Intelligent Lab on Fiber is a patented photonics and Artificial Intelligence system identifies unique features of various gold-standard biomarkers, capturing their signature on a cloud-based library. | $4.1M |  | Jul 28, 2022 |  |
| iLoF | iLoF - Intelligent Lab on Fiber is a patented photonics and Artificial Intelligence system identifies unique features of various gold-standard biomarkers, capturing their signature on a cloud-based library. | $4.1M | Seed | Jul 28, 2022 |  |
| Alena | Alena uses neuroscience-based games to assess the user’s behaviour and identify thinking patterns that drive key mental health disorders. Using this deeper understanding, Alena suggests the most optimal intervention and dynamically adapts to the user's changing needs. Alena was founded in 2019 in London bringing together leading figuresfrom the world of computational neuroscience, psychiatry and user-centric innovation. You can learn more about Alena on our website: www.alena.com | $2.7M | Seed | Mar 23, 2022 |  |
| Centenara Labs | Rejuveron Life Sciences AG is a fully integrated biotechnology platform company that invests in people and ideas to develop therapies and technologies to improve healthy aging and prolong lifespan. |  | Series B | Mar 17, 2022 |  |
| OccamzRazor | OccamzRazor combines machine learning and first-in-class biological techniques to improve outcomes in drug discovery and development. Our analysis pipeline consists of two proprietary technologies, Panoramic AI and RazorBrain. Together, they are designed to extract data from unstructured text sources (publications, patient reported outcomes, etc.)and join them with structured data (genomics, proteomics, phenomics, etc.) to generate stronger drug discovery hypotheses and more valuable insights. Successful applications include data extraction and curation from biomedical text, novel target identification, and drug repurposing/repositioning. | $6.1M | Series A | Mar 08, 2022 |  |
| CereGate | CereGate is a Brain-Machine Interface company establishing new ways of communication. |  | Series A | Jan 12, 2022 |  |
| CereGate | CereGate is a Brain-Machine Interface company establishing new ways of communication. |  | Convertible Note | Jan 12, 2022 |  |

10 of 19 investments shown.

## Co-investors
- [Presight Capital](https://shizune.co/investors/profile/presight-capital) — VC Fund, 4 deals together
- [Palo Santo Fund](https://shizune.co/investors/profile/palo-santo-venture-fund) — VC Fund, 3 deals together
- [PsyMed Ventures](https://shizune.co/investors/profile/psychedelic-medicine-syndicate) — VC Fund, 3 deals together
- [What If Ventures](https://shizune.co/investors/profile/what-if-ventures) — VC Fund, 3 deals together
- WPSS.bio — VC Fund, 3 deals together
- [468 Capital](https://shizune.co/investors/profile/468-capital) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does re.Mind Capital invest in?

re.Mind Capital invests primarily in Medical, Health Care and Biotechnology startups, most often at Series A and Seed stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact re.Mind Capital?

Public channels for re.Mind Capital include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at re.Mind Capital?

The team at re.Mind Capital includes Jan Hardorp (Founding Partner). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co